Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial [0.03%]
间断扫描血糖监测切换为实时动态葡萄糖监测对1型糖尿病成人患者影响：ALERTT1随机试验的24个月结果
Margaretha M Visser,Sara Charleer,Steffen Fieuws et al.
Margaretha M Visser et al.
Background: Comparing Continuous With Flash Glucose Monitoring In Adults With Type 1 Diabetes (ALERTT1) examined whether switching from first-generation intermittently scanned continuous glucose monitoring (isCGM) without...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2023 Feb;11(2):96-108. DOI:10.1016/S2213-8587(22)00352-7 2023
Marta Koch,Parizad Avari
Marta Koch
Insulin products and patents in the USA in 2004, 2014, and 2020: a cross-sectional study [0.03%]
美国胰岛素产品及专利情况在2004、2014和2020年的横断面研究
Victor L Van de Wiele,Aaron S Kesselheim,David Beran et al.
Victor L Van de Wiele et al.
Kamlesh Khunti,Chantal Mathieu,Bart Torbeyns et al.
Kamlesh Khunti et al.
Kirsten Nørgaard,Ulrik Pedersen-Bjergaard
Kirsten Nørgaard
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
David Beran,Carol Abidha,Amanda Adler et al.
David Beran et al.